Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$147.40
-0.86-0.58%
Última actualización: Nov 17, 9:30 AM
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Lam Research Corp tiene un precio objetivo de consenso de $142.4 basado en las calificaciones de 27 analistas. El máximo es $200, emitido por Susquehanna el octubre 23, 2025. El mínimo es $85, emitido por Bernstein el noviembre 29, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por Citigroup, UBS y JP Morgan el noviembre 12, 2025, octubre 23, 2025 y octubre 23, 2025, respectivamente. Con un precio objetivo promedio de $173.33 entre Citigroup, UBS y JP Morgan, hay una 17.57% upside implícita para Lam Research Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Citigroup
UBS
JP Morgan
Susquehanna
B. Riley Securities
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Lam Research
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/12/2025 | 28.87% | Citigroup | $175 → $190 | Maintains | Buy | |||
10/23/2025 | 11.91% | UBS | $155 → $165 | Maintains | Buy | |||
10/23/2025 | 11.91% | JP Morgan | $113 → $165 | Maintains | Overweight | |||
10/23/2025 | 35.65% | Susquehanna | $135 → $200 | Maintains | Positive | |||
10/23/2025 | 22.09% | B. Riley Securities | $175 → $180 | Maintains | Buy | |||
10/23/2025 | 15.31% | TD Cowen | $145 → $170 | Maintains | Buy | |||
10/23/2025 | 8.52% | Stifel | $135 → $160 | Maintains | Buy | |||
10/23/2025 | -1.65% | Wells Fargo | $135 → $145 | Maintains | Equal-Weight | |||
10/23/2025 | 35.65% | Oppenheimer | $120 → $200 | Maintains | Outperform | |||
10/23/2025 | 15.31% | Mizuho | $162 → $170 | Maintains | Outperform | |||
10/23/2025 | -7.08% | Morgan Stanley | $125 → $137 | Maintains | Equal-Weight | |||
10/23/2025 | 18.7% | Citigroup | $120 → $175 | Maintains | Buy | |||
10/23/2025 | 8.52% | Needham | $150 → $160 | Maintains | Buy | |||
10/20/2025 | -3.69% | Barclays | $83 → $142 | Maintains | Equal-Weight | |||
10/16/2025 | 9.88% | Mizuho | $130 → $162 | Maintains | Outperform | |||
10/13/2025 | -8.43% | Stifel | $115 → $135 | Maintains | Buy | |||
10/09/2025 | 8.52% | Goldman Sachs | $115 → $160 | Maintains | Buy | |||
09/30/2025 | -13.86% | HSBC | → $127 | Initiates | → Hold | |||
09/29/2025 | 1.74% | Deutsche Bank | $100 → $150 | Upgrade | Hold → Buy | |||
09/24/2025 | 8.52% | B. Riley Securities | $130 → $160 | Maintains | Buy | |||
09/23/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
09/22/2025 | -15.22% | Morgan Stanley | $92 → $125 | Upgrade | Underweight → Equal-Weight | |||
09/12/2025 | -11.83% | Mizuho | $120 → $130 | Maintains | Outperform | |||
09/08/2025 | -18.61% | Citigroup | $113 → $120 | Maintains | Buy | |||
09/02/2025 | -37.6% | Morgan Stanley | $94 → $92 | Downgrade | Equal-Weight → Underweight | |||
08/21/2025 | -18.61% | Cantor Fitzgerald | $115 → $120 | Maintains | Overweight | |||
08/01/2025 | -23.36% | Citigroup | $108 → $113 | Maintains | Buy | |||
08/01/2025 | -18.61% | Argus Research | $105 → $120 | Maintains | Buy | |||
08/01/2025 | -18.61% | Mizuho | $115 → $120 | Maintains | Outperform | |||
07/31/2025 | -33.53% | Wells Fargo | $95 → $98 | Maintains | Equal-Weight | |||
07/31/2025 | -22% | Stifel | $110 → $115 | Maintains | Buy | |||
07/31/2025 | -36.24% | Morgan Stanley | $87 → $94 | Maintains | Equal-Weight | |||
07/31/2025 | -25.39% | Raymond James | $90 → $110 | Maintains | Outperform | |||
07/31/2025 | -18.61% | Oppenheimer | $110 → $120 | Maintains | Outperform | |||
07/31/2025 | -22% | Needham | $110 → $115 | Maintains | Buy | |||
07/29/2025 | -25.39% | Stifel | $92 → $110 | Maintains | Buy | |||
07/28/2025 | -43.7% | Barclays | $70 → $83 | Maintains | Equal-Weight | |||
07/21/2025 | -18.61% | UBS | $95 → $120 | Maintains | Buy | |||
07/15/2025 | -22% | Keybanc | $105 → $115 | Maintains | Overweight | |||
07/14/2025 | -22% | Mizuho | $100 → $115 | Maintains | Outperform | |||
07/10/2025 | -22% | Goldman Sachs | → $115 | Initiates | → Buy | |||
07/08/2025 | -35.56% | Wells Fargo | $75 → $95 | Maintains | Equal-Weight | |||
07/07/2025 | -26.75% | Citigroup | $87 → $108 | Maintains | Buy | |||
07/01/2025 | -40.99% | Morgan Stanley | $82 → $87 | Maintains | Equal-Weight | |||
06/24/2025 | -22% | Cantor Fitzgerald | $90 → $115 | Maintains | Overweight | |||
06/18/2025 | -22% | B. Riley Securities | $95 → $115 | Maintains | Buy | |||
06/17/2025 | -25.39% | Oppenheimer | $80 → $110 | Maintains | Outperform | |||
04/24/2025 | -35.56% | UBS | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -35.56% | JP Morgan | $110 → $95 | Maintains | Overweight | |||
04/24/2025 | -38.96% | Raymond James | $100 → $90 | Maintains | Outperform | |||
04/24/2025 | -52.52% | Deutsche Bank | $78 → $70 | Maintains | Hold | |||
04/24/2025 | -35.56% | B. Riley Securities | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -45.74% | Needham | $96 → $80 | Maintains | Buy | |||
04/24/2025 | -44.38% | Morgan Stanley | $81 → $82 | Maintains | Equal-Weight | |||
04/24/2025 | -38.96% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
04/24/2025 | -32.17% | TD Securities | $110 → $100 | Maintains | Buy | |||
04/24/2025 | -49.13% | Wells Fargo | $85 → $75 | Maintains | Equal-Weight | |||
04/24/2025 | -32.85% | Evercore ISI Group | $95 → $99 | Maintains | Outperform | |||
04/22/2025 | -52.52% | Barclays | $75 → $70 | Maintains | Equal-Weight | |||
04/16/2025 | -38.96% | B of A Securities | $110 → $90 | Maintains | Buy | |||
04/15/2025 | -37.6% | Stifel | $100 → $92 | Maintains | Buy | |||
04/14/2025 | -38.96% | UBS | $95 → $90 | Maintains | Buy | |||
04/11/2025 | -45.74% | Oppenheimer | $95 → $80 | Maintains | Outperform | |||
03/28/2025 | -32.17% | Jefferies | $95 → $100 | Maintains | Buy | |||
03/20/2025 | -35.56% | Oppenheimer | → $95 | Initiates | → Outperform | |||
02/20/2025 | -28.78% | Keybanc | $95 → $105 | Maintains | Overweight | |||
02/20/2025 | -25.39% | B of A Securities | $100 → $110 | Maintains | Buy | |||
02/20/2025 | -15.22% | Susquehanna | $75 → $125 | Upgrade | Neutral → Positive | |||
02/20/2025 | -32.17% | Mizuho | $87 → $100 | Maintains | Outperform | |||
02/20/2025 | -32.17% | Cantor Fitzgerald | $100 → $100 | Reiterates | Overweight → Overweight | |||
02/18/2025 | -32.17% | Cantor Fitzgerald | $100 → $100 | Maintains | Overweight | |||
01/31/2025 | -47.1% | Deutsche Bank | $76 → $78 | Maintains | Hold | |||
01/30/2025 | -45.06% | Morgan Stanley | $78 → $81 | Maintains | Equal-Weight | |||
01/30/2025 | -40.99% | Mizuho | $90 → $87 | Maintains | Outperform | |||
01/30/2025 | -32.17% | Cantor Fitzgerald | $95 → $100 | Upgrade | Neutral → Overweight | |||
01/30/2025 | -42.35% | Wells Fargo | $82 → $85 | Maintains | Equal-Weight | |||
01/30/2025 | -38.96% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/17/2025 | -35.56% | Keybanc | $95 → $95 | Upgrade | Sector Weight → Overweight | |||
01/17/2025 | -49.13% | Barclays | $90 → $75 | Maintains | Equal-Weight | |||
01/15/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/13/2025 | -38.96% | Needham | $100 → $90 | Maintains | Buy | |||
01/13/2025 | -44.38% | Wells Fargo | $83 → $82 | Maintains | Equal-Weight | |||
01/10/2025 | -38.96% | Mizuho | $95 → $90 | Maintains | Outperform | |||
01/10/2025 | -42.35% | Goldman Sachs | $96 → $85 | Maintains | Buy | |||
12/06/2024 | -43.7% | Wells Fargo | $85 → $83 | Maintains | Equal-Weight | |||
12/05/2024 | -47.1% | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
11/29/2024 | -42.35% | Bernstein | $95 → $85 | Maintains | Market Perform | |||
10/24/2024 | -32.17% | Cantor Fitzgerald | $100 → $100 | Reiterates | Neutral → Neutral | |||
10/24/2024 | -48.45% | Morgan Stanley | $77 → $76 | Maintains | Equal-Weight | |||
10/24/2024 | -32.17% | Stifel | $105 → $100 | Reiterates | Buy → Buy | |||
10/24/2024 | -42.35% | Wells Fargo | $88 → $85 | Maintains | Equal-Weight | |||
10/24/2024 | -25.39% | B. Riley Securities | $105 → $110 | Reiterates | Buy → Buy | |||
10/24/2024 | -32.17% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
10/03/2024 | 496.87% | Wells Fargo | $1000 → $880 | Maintains | Equal-Weight | |||
09/30/2024 | 578.26% | Cantor Fitzgerald | $1200 → $1000 | Maintains | Neutral | |||
09/20/2024 | 544.35% | Mizuho | $1050 → $950 | Maintains | Outperform | |||
09/17/2024 | 424.98% | Morgan Stanley | $929 → $774 | Maintains | Equal-Weight | |||
09/16/2024 | 505.69% | Citigroup | $990 → $893 | Maintains | Buy | |||
09/12/2024 | 680% | UBS | $1250 → $1150 | Maintains | Buy | |||
08/05/2024 | 571.48% | Citigroup | $1025 → $990 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Lam Research (LRCX)?
El último precio objetivo de Lam Research (NASDAQ:LRCX) fue comunicado por Citigroup el noviembre 12, 2025. La firma de analistas fijó un precio objetivo para $190.00 que espera LRCX a rise dentro de 12 meses (un posible 28.90% upside). 87 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Lam Research (LRCX)?
La última calificación de analistas para Lam Research (NASDAQ:LRCX) fue proporcionada por Citigroup, y Lam Research mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de Lam Research (LRCX)?
La última revisión al alza de Lam Research Corp se produjo en septiembre 29, 2025, cuando Deutsche Bank elevó su precio objetivo a $150. Deutsche Bank anteriormente tenía a hold para Lam Research Corp.
¿Cuándo fue la última revisión a la baja de Lam Research (LRCX)?
La última revisión a la baja de Lam Research Corp se produjo en septiembre 23, 2025, cuando Keybanc cambió su precio objetivo de N/A a N/A para Lam Research Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Lam Research (LRCX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Lam Research, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Lam Research se registró el noviembre 12, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 12, 2026.
¿Es correcta la calificación de los analistas sobre Lam Research (LRCX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Lam Research (LRCX) fue un mantuvo con un precio objetivo de $175.00 a $190.00. El precio actual al que cotiza Lam Research (LRCX) es de $147.40, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.